<?xml version="1.0" encoding="UTF-8"?>
<ref id="R2">
 <label>2</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>N</given-names>
   </name>, 
   <name name-style="western">
    <surname>Tu</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>X</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action</article-title>. 
  <source>Immunotherapy</source>
  <year>2019</year>;
  <volume>11</volume>:
  <fpage>429</fpage>â€“
  <lpage>41</lpage>. 
  <pub-id pub-id-type="doi">10.2217/imt-2018-0110</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/30698054?>
  <pub-id pub-id-type="pmid">30698054</pub-id>
 </mixed-citation>
</ref>
